- Capital Cube•4 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to IRIDEX Corp. Here are 5 ETFs with the largest exposure to IRIX-US. Comparing the performance and risk of IRIDEX Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- PR Newswire•14 days ago
MOUNTAIN VIEW, Calif., Jan. 9, 2017 /PRNewswire/ -- IRIDEX Corporation (IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the fourth quarter and full year 2016, respectively, meeting the previously provided quarterly and full year guidance provided by the Company. Revenue growth compared to fourth quarter and full year 2015 was driven by the Company's new flagship Cyclo G6™ glaucoma laser platform that is powered by the Company's proprietary MicroPulse™ technology. The Company expects to release its complete fourth quarter and full year 2016 results in early March 2017, at which time, the Company will provide guidance for full year 2017.
- PR Newswire•last month
MOUNTAIN VIEW, Calif., Dec. 9, 2016 /PRNewswire/ -- IRIDEX Corporation (IRIX) today announced the pricing of its underwritten public offering of an aggregate of 1.15 million shares of common stock at a price of $14.00 per share, $0.01 par value (the "Offering" with such shares being the "Shares"). IRIDEX expects to receive gross proceeds of $16.1 million, before deducting underwriting discounts and other estimated offering expenses. IRIDEX has also granted the underwriters a 30-day option to purchase up to 172,500 shares of common stock to cover over-allotments, if any. Roth Capital Partners is acting as sole manager for the Offering.
IRIX : Summary for IRIDEX Corporation - Yahoo Finance
IRIDEX Corporation (IRIX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||13.24 - 13.83|
|52 Week Range||8.34 - 16.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-292.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|